These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7880654)

  • 21. [Coasting: a response to excessive ovarian stimulation].
    Dechaud H; Anahory T; Aligier N; Arnal F; Humeau C; Hédon B
    Gynecol Obstet Fertil; 2000 Feb; 28(2):115-9. PubMed ID: 10758585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis.
    Grochowski D; Sola E; Kulikowski M; Kuczyński W; Wołczyński S; Szamatowicz M
    J Assist Reprod Genet; 1995 Jul; 12(6):394-6. PubMed ID: 8589562
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute cerebrovascular accidents with severe ovarian hyperstimulation syndrome.
    El Sadek MM; Amer MK; Fahmy M
    Hum Reprod; 1998 Jul; 13(7):1793-5. PubMed ID: 9740425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders.
    Amit A; Yaron Y; Yovel I; Peyser MR; David MP; Botchan A; Lessing JB
    Hum Reprod; 1993 Aug; 8(8):1184-6. PubMed ID: 8408514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of ovarian hyperstimulation syndrome. Produced on behalf of the BFS Policy and Practice Committee.
    Tan BK; Mathur R
    Hum Fertil (Camb); 2013 Sep; 16(3):151-9. PubMed ID: 23705784
    [No Abstract]   [Full Text] [Related]  

  • 27. Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
    Casper RF
    Hum Reprod; 1996 Jun; 11(6):1144-6. PubMed ID: 8671408
    [No Abstract]   [Full Text] [Related]  

  • 28. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient.
    Levy T; Orvieto R; Homburg R; Peleg D; Dekel A; Ben-Rafael Z
    Hum Reprod; 1996 Jun; 11(6):1177-9. PubMed ID: 8671418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total ovarian volume before human chorionic gonadotrophin administration for ovulation induction may predict the hyperstimulation syndrome.
    Oyesanya OA; Parsons JH; Collins WP; Campbell S
    Hum Reprod; 1995 Dec; 10(12):3211-12. PubMed ID: 8822446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of prerenal azotaemia associated with severe ovarian hyperstimulation syndrome.
    Peces R; Escalada P; Sánchez-Fructuoso A; de la Torre M
    Nephrol Dial Transplant; 1994; 9(3):326-8. PubMed ID: 8052444
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe ovarian hyperstimulation syndrome following salvage of empty follicle syndrome.
    Evbuomwan IO; Fenwick JD; Shiels R; Herbert M; Murdoch AP
    Hum Reprod; 1999 Jul; 14(7):1707-9. PubMed ID: 10402372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteal phase defects in assisted reproduction: the role of luteal phase supplementation.
    Capitanio GL; Ubaldi F; Giannini P; Croce S
    Acta Eur Fertil; 1992; 23(1):15-9. PubMed ID: 1293894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of 17 beta-estradiol levels in highly responding women during ovulation induction in IVF treatment: its impact and prognostic value with respect to oocyte maturation and treatment outcome.
    Ben-Nun I; Shulman A; Ghetler Y; Shilon M; Kaneti H; Beyth Y
    J Assist Reprod Genet; 1993 Apr; 10(3):213-5. PubMed ID: 8400733
    [No Abstract]   [Full Text] [Related]  

  • 34. Defining case-control studies.
    Ntui A; Shendre A; Lee L; McGwin G
    Fertil Steril; 2011 Jun; 95(8):e59; author reply e60. PubMed ID: 21536275
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathophysiology and current clinical approach of ovarian hyperstimulation syndrome].
    Szabó G; Árokszállási A; Pócsi D; Murber Á; Urbancsek J; Rigó J
    Orv Hetil; 2018 Aug; 159(34):1390-1398. PubMed ID: 30122058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian hyperstimulation: effects of GnRH analogues. Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase.
    Ben-Arie A; Weissman A; Shoham Z
    Hum Reprod; 1996 Jun; 11(6):1146-8. PubMed ID: 8671409
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intensive care and treatment of severe ovarian hyperstimulation syndrome].
    Ma MY; Wen WB; Zhou LX; Yu TO; Fang B
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1212-4. PubMed ID: 15485803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the high-risk patient for ovarian hyperstimulation syndrome.
    Papanikolaou EG; Humaidan P; Polyzos NP; Tarlatzis B
    Semin Reprod Med; 2010 Nov; 28(6):458-62. PubMed ID: 21082503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aorto-subclavian thromboembolism: a rare complication associated with moderate ovarian hyperstimulation syndrome.
    Germond M; Wirthner D; Thorin D; Ruchat P; Essinger A; De Grandi P
    Hum Reprod; 1996 Jun; 11(6):1173-6. PubMed ID: 8671417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.